pentobarbital will decrease the level or outcome of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Keep away from coadministration of bedaquiline with solid CYP3A4 inducers on account of possible for reduced therapeutic influencePhenobarbital appears to interfere With all the absorption